Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: The FAST-3 trial
William R. Lumry, H. Henry Li, Robyn J. Levy, Paul C. Potter, Henriette Farkas, Dumitru Moldovan, Marc Riedl, Hongbin Li, Timothy Craig, Bradley J. Bloom, Avner Reshef
Dive into the research topics of 'Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: The FAST-3 trial'. Together they form a unique fingerprint.